Clinical Trials Directory

Trials / Unknown

UnknownNCT05103956

Hemostatic Patch/Collagen Sealant and Polyethylene Glycol (Hemopatch) in the Postoperative of the Thyroidectomy.

Regular Treatment Versus Hemostatic Patch/Collagen Sealant and Polyethylene Glycol (Hemopatch) in the Immediate Postoperative of the Thyroidectomy, Unicentric Study, Non-inferiority, Open and Randomized (Tiropatch Study)

Status
Unknown
Phase
Study type
Observational
Enrollment
108 (estimated)
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Observational study with non-inferiority, prospective, randomized (1: 1) and open-label medical device. The study has 2 treatment groups (HEMOPATCH® versus standard hemostasis).

Detailed description

The main objective is to determine if there is a reduction in the volume of exudate in the surgical bed with the application of the collagen and polyethylene glycol hemostatic agent. The present study includes patients undergoing total thyroidectomy for multinodular goiter in the Endocrine Surgery Unit of the Virgen del Rocío University Hospital. The estimated sample calculation of patients enrolled in the study is 108 (2 groups, 1:1 ratio). The patients don´t know what type of hemostatic the patients are going to receive (single blind). The duration of patient follow-up will be 30 +/- 10 days after surgery.

Conditions

Timeline

Start date
2021-10-01
Primary completion
2022-04-01
Completion
2022-04-01
First posted
2021-11-02
Last updated
2021-11-17

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05103956. Inclusion in this directory is not an endorsement.